A detailed history of Pura Vida Investments, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Pura Vida Investments, LLC holds 38,005 shares of TXG stock, worth $711,453. This represents 1.02% of its overall portfolio holdings.

Number of Shares
38,005
Holding current value
$711,453
% of portfolio
1.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$36.08 - $54.3 $1.37 Million - $2.06 Million
38,005 New
38,005 $1.43 Million
Q2 2022

Aug 15, 2022

SELL
$36.95 - $82.41 $822,396 - $1.83 Million
-22,257 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$55.7 - $145.79 $2.21 Million - $5.79 Million
-39,700 Reduced 64.08%
22,257 $1.69 Million
Q4 2021

Feb 14, 2022

SELL
$135.05 - $182.59 $230,125 - $311,133
-1,704 Reduced 2.68%
61,957 $9.23 Million
Q3 2021

Nov 15, 2021

SELL
$145.58 - $192.14 $142,086 - $187,528
-976 Reduced 1.51%
63,661 $9.27 Million
Q2 2021

Aug 16, 2021

SELL
$134.22 - $202.37 $814,312 - $1.23 Million
-6,067 Reduced 8.58%
64,637 $12.7 Million
Q1 2021

May 12, 2021

BUY
$140.25 - $196.86 $3.96 Million - $5.55 Million
28,204 Added 66.36%
70,704 $12.8 Million
Q4 2020

Feb 16, 2021

SELL
$126.47 - $163.7 $4.07 Million - $5.27 Million
-32,220 Reduced 43.12%
42,500 $6.02 Million
Q3 2020

Nov 16, 2020

BUY
$87.44 - $125.0 $2.69 Million - $3.85 Million
30,800 Added 70.13%
74,720 $9.32 Million
Q2 2020

Aug 14, 2020

SELL
$58.39 - $89.31 $624,773 - $955,617
-10,700 Reduced 19.59%
43,920 $3.92 Million
Q1 2020

May 15, 2020

SELL
$51.57 - $106.62 $1.69 Million - $3.49 Million
-32,720 Reduced 37.46%
54,620 $3.4 Million
Q4 2019

Feb 14, 2020

SELL
$46.07 - $79.54 $122,546 - $211,576
-2,660 Reduced 2.96%
87,340 $6.66 Million
Q3 2019

Nov 14, 2019

BUY
$49.99 - $62.0 $4.5 Million - $5.58 Million
90,000 New
90,000 $4.54 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.78B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.